TY - JOUR
T1 - The missing medians
T2 - Exclusion of ordinal data from meta-analyses
AU - Cumming, Toby B.
AU - Churilov, Leonid
AU - Sena, Emily S.
N1 - Publisher Copyright:
©2015 Cumming et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source arecredited.
PY - 2015/12/23
Y1 - 2015/12/23
N2 - Background Meta-analyses are considered the gold standard of evidence-based health care, and are used to guide clinical decisions and health policy. A major limitation of current meta-analysis techniques is their inability to pool ordinal data. Our objectives were to determine the extent of this problem in the context of neurological rating scales and to provide a solution. Methods Using an existing database of clinical trials of oral neuroprotective therapies, we identified the 6 most commonly used clinical rating scales and recorded how data from these scales were reported and analysed. We then identified systematic reviews of studies that used these scales (via the Cochrane database) and recorded the meta-analytic techniques used. Finally, we identified a statistical technique for calculating a common language effect size measure for ordinal data. Results We identified 103 studies, with 128 instances of the 6 clinical scales being reported. The majority- 80%-reported means alone for central tendency, with only 13% reporting medians. In analysis, 40% of studies used parametric statistics alone, 34% of studies employed non-parametric analysis, and 26% did not include or specify analysis. Of the 60 systematic reviews identified that included meta-analysis, 88% used mean difference and 22% employed difference in proportions; none included rank-based analysis. We propose the use of a rank-based generalised odds ratio (WMW GenOR) as an assumptionfree effect size measure that is easy to compute and can be readily combined in metaanalysis. Conclusion There is wide scope for improvement in the reporting and analysis of ordinal data in the literature. We hope that adoption of the WMWGenOR will have the dual effect of improving thereporting of data in individual studies while also increasing the inclusivity (and therefore validity) of meta-analyses.
AB - Background Meta-analyses are considered the gold standard of evidence-based health care, and are used to guide clinical decisions and health policy. A major limitation of current meta-analysis techniques is their inability to pool ordinal data. Our objectives were to determine the extent of this problem in the context of neurological rating scales and to provide a solution. Methods Using an existing database of clinical trials of oral neuroprotective therapies, we identified the 6 most commonly used clinical rating scales and recorded how data from these scales were reported and analysed. We then identified systematic reviews of studies that used these scales (via the Cochrane database) and recorded the meta-analytic techniques used. Finally, we identified a statistical technique for calculating a common language effect size measure for ordinal data. Results We identified 103 studies, with 128 instances of the 6 clinical scales being reported. The majority- 80%-reported means alone for central tendency, with only 13% reporting medians. In analysis, 40% of studies used parametric statistics alone, 34% of studies employed non-parametric analysis, and 26% did not include or specify analysis. Of the 60 systematic reviews identified that included meta-analysis, 88% used mean difference and 22% employed difference in proportions; none included rank-based analysis. We propose the use of a rank-based generalised odds ratio (WMW GenOR) as an assumptionfree effect size measure that is easy to compute and can be readily combined in metaanalysis. Conclusion There is wide scope for improvement in the reporting and analysis of ordinal data in the literature. We hope that adoption of the WMWGenOR will have the dual effect of improving thereporting of data in individual studies while also increasing the inclusivity (and therefore validity) of meta-analyses.
UR - https://www.scopus.com/pages/publications/84956875393
U2 - 10.1371/journal.pone.0145580
DO - 10.1371/journal.pone.0145580
M3 - Article
C2 - 26697876
AN - SCOPUS:84956875393
SN - 1932-6203
VL - 10
JO - PLoS ONE
JF - PLoS ONE
IS - 12
M1 - e0145580
ER -